Status:

RECRUITING

Interest of Auriculotherapy in the Treatment of Xerostomia

Lead Sponsor:

Hopital Foch

Conditions:

Xerostomia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of the study is to show that auriculotherapy is effective in the treatment of xerostomia

Eligibility Criteria

Inclusion Criteria:

  • Patients over 18 years old;
  • Complain about xerostomia after cervical irradiation in the context of ENT cancer;
  • End of radiotherapy> 3 months
  • Covered by a national healthcare insurance
  • Consent form signed.

Non inclusion Criteria:

  • Pregnant or breastfeeding women;
  • Local counterindication to auriculotherapy;
  • With anticoagulant treatment;
  • History or existing of hemophilia;
  • Valvular prosthesis;
  • Ear's pavilion infection;
  • Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months;
  • Having started in the 48 hours preceding the first auriculotherapy session, any new management of xerostomia and likely to interfere with the study (specific medication and/or complementary therapeutic management);
  • Difficulty to comply with the treatment, questionnaires or study protocol;
  • Being deprived of liberty or under guardianship.

Key Trial Info

Start Date :

December 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 4 2025

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT04222478

Start Date

December 4 2019

End Date

December 4 2025

Last Update

February 12 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Centre Hospitalier Régional Universitaire de Brest - Hôpital Morvan

Brest, Brittany Region, France, 29600

2

Hôpital Forcilles

Férolles-Attilly, France, 77150

3

GHP Saint Joseph

Paris, France, 75014

4

Hôpital Foch

Suresnes, France, 92150

Interest of Auriculotherapy in the Treatment of Xerostomia | DecenTrialz